Actively Recruiting
Developing a Decision Support Tool for Women with Small, Symptom-Free Uterine Leiomyoma Analyzing Factors Affecting Treatment Choices Using High-Intensity Focused Ultrasound
Led by Shenzhen Maternity & Child Healthcare Hospital · Updated on 2022-08-12
120
Participants Needed
1
Research Sites
156 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are investigating decision-making in women with asymptomatic small leiomyoma, a condition involving benign uterine tumors. This study aims to understand factors influencing clinical decisions and to develop a patient decision aid tool based on clinical guidelines and evidence-based medicine. The study involves collaboration among designers, doctors, nurses, and patients to improve patient decision-making and reported outcomes. Participants receive one of two communication approaches traditional discussion with their healthcare providers or a discussion supported by a patient decision aid tool designed to help patients understand treatment options and outcomes. This tool encourages patient involvement in decisions by providing clear information about benefits and risks related to their health status. During the study, patient satisfaction with decision-making will be monitored over 6 to 12 months. Participants and their families are expected to follow up regularly. The study measures how the use of this decision aid tool impacts patient satisfaction and the quality of their treatment decisions, with ongoing assessments to support understanding and adherence.
CONDITIONS
Brief Title
Establishment of a Decision Aid Tool for Asymptomatic Small Leiomyoma and Analysis of Influencing Factors for Clinical Decision-making Using HIFU
Research Team
Y
Yu Dai, Associate Professor
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here